Immunogenicity, safety and tolerability of monovalent 2009 pandemic influenza A/H1N1 MF59-adjuvanted vaccine in patients with β-thalassemia major.
about
Potential impact of co-infections and co-morbidities prevalent in Africa on influenza severity and frequency: a systematic reviewAssessment of antigen-specific and cross-reactive antibody responses to an MF59-adjuvanted A/H5N1 prepandemic influenza vaccine in adult and elderly subjects.Immunogenicity and safety of cell-derived MF59®-adjuvanted A/H1N1 influenza vaccine for childrenA dose-ranging study in older adults to compare the safety and immunogenicity profiles of MF59®-adjuvanted and non-adjuvanted seasonal influenza vaccines following intradermal and intramuscular administration.Adjuvanted influenza vaccines.
P2860
Immunogenicity, safety and tolerability of monovalent 2009 pandemic influenza A/H1N1 MF59-adjuvanted vaccine in patients with β-thalassemia major.
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Immunogenicity, safety and tol ...... ents with β-thalassemia major.
@ast
Immunogenicity, safety and tol ...... ents with β-thalassemia major.
@en
type
label
Immunogenicity, safety and tol ...... ents with β-thalassemia major.
@ast
Immunogenicity, safety and tol ...... ents with β-thalassemia major.
@en
prefLabel
Immunogenicity, safety and tol ...... ents with β-thalassemia major.
@ast
Immunogenicity, safety and tol ...... ents with β-thalassemia major.
@en
P2093
P1433
P1476
Immunogenicity, safety and tol ...... ents with β-thalassemia major.
@en
P2093
Alessia Scala
Carlotta Galeone
Cristina Daleno
Domenico Serra
Emanuela D'Angelo
Francesco Peia
Nadia Mirra
Susanna Esposito
P304
P356
10.1016/J.VACCINE.2010.09.058
P407
P577
2010-10-01T00:00:00Z